Auditory Rehabilitation in Stroke Patients With Auditory Processing Disorders
NCT ID: NCT02889107
Last Updated: 2016-09-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
9 participants
INTERVENTIONAL
2013-04-30
2016-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Listen in: Developing and Testing a Therapy Application for Patients With Speech Comprehension Deficits After Stroke.
NCT02540889
Electro-physiological Signs to Prognostic Aphasia Recovery After a Stroke
NCT03103230
Speech Therapy for Aphasia: Comparing Two Treatments
NCT02153710
Auditory Masking Effects on Speech Fluency in Aphasia and Apraxia of Speech
NCT02094014
Using Augmentative & Alternative Communication to Promote Language Recovery for People With Post-Stroke Aphasia
NCT04081207
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
standard care
Patients received standard listening strategies for 10 weeks
No interventions assigned to this group
intervention
Patients received an assistive listening device (personal frequency modulated systems) for 10 weeks
personal frequency modulated systems
patients used personal frequency modulated systems for at least 4 hours daily for 10 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
personal frequency modulated systems
patients used personal frequency modulated systems for at least 4 hours daily for 10 weeks
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of auditory processing disorders
* Normal pure-tone audiogram
Exclusion Criteria
* Significant psychiatric illnesses
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University College, London
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Doris-Eva Bamiou
Reader & Consultant in Audiovestibular Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Doris-Eva Bamiou, PhD
Role: PRINCIPAL_INVESTIGATOR
University College, London
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University College London Hospitals
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Koohi N, Vickers D, Warren J, Werring D, Bamiou DE. Long-term use benefits of personal frequency-modulated systems for speech in noise perception in patients with stroke with auditory processing deficits: a non-randomised controlled trial study. BMJ Open. 2017 Apr 7;7(4):e013003. doi: 10.1136/bmjopen-2016-013003.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
11/LO/1675
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.